Healthcare & Medical Devices Global On demand · 24-48h

Global Disposable Urinary Catheter Market Strategic Research Report

Global Disposable Urinary Catheter Market Strategic Research…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Disposable Urinary Catheter Market
$3.21B2025
6.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Intermittent Catheters, Indwelling Foley Catheters, Others

By Application: Hospitals and Clinics, Homecare, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Coloplast, Hollister, Teleflex, B. Braun, BD, Convatec, Wellspect HealthCare, Medline Industries, Cardinal Health, Cook Medical, Urocare Products, Create Medic, Fuji Systems, Well Lead Medical, Baihe Medical, KDL Medical, Weigao Group

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 142 pages
Market size 2025
$3.21B
Billion USD
Forecast CAGR
6.4%
2025-2032
Forecast 2032
$5B
Projected
Regionen
5
Asia Pacific · Latin America · MEA · Europe · North America

Übersicht

Scope of the Report

The global Disposable Urinary Catheter market size is predicted to grow from US$ 3,205 million in 2025 to US$ 4,766 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032.

Disposable urinary catheters are sterile single-use or short-term catheter products designed for urine drainage, bladder management, intraoperative urine-output monitoring and urological procedures. They are commonly made from medical-grade latex, PVC, silicone, TPU or other biocompatible materials, and can be classified into disposable intermittent catheters, disposable indwelling Foley catheters, hydrophilic-coated catheters and antimicrobial or anti-infection catheters. In 2025, Global disposable urinary catheters sales are estimated at about 6,300 million units, with an average ex-works price of around 0.52 US$/Unit. The value chain includes upstream medical PVC, silicone, latex, TPU, hydrophilic coatings, lubricants, sterile packaging and catheter connectors; midstream catheter and catheter-kit manufacturers; and downstream users including hospitals, urology departments, ICUs, operating rooms, long-term care facilities, rehabilitation centers and home-care channels.

The disposable urinary catheter market is mainly driven by population aging, rising surgical volumes, increasing prevalence of urological diseases and neurogenic bladder, and growing demand for long-term care and home-based care. Elderly patients, post-operative patients, people with spinal cord injury, prostate-related conditions and disabled care populations require continuous bladder management and urine drainage, supporting stable consumption in both hospital and out-of-hospital settings. At the same time, stronger infection-control requirements and greater attention to catheter-associated urinary tract infection (CAUTI) prevention are accelerating the shift toward single-use, hydrophilic-coated, pre-lubricated and antimicrobial catheter products. As patient acceptance of self-catheterization improves, reimbursement coverage expands and medical-consumable penetration rises in emerging markets, disposable urinary catheters are expected to maintain steady growth, although centralized procurement, cost-control policies and product homogenization may pressure manufacturers'margins.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Disposable Urinary Catheter market?

What factors are driving Disposable Urinary Catheter market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Disposable Urinary Catheter market opportunities vary by end market size?

How does Disposable Urinary Catheter break out by Type, by Application?

This report presents a comprehensive overview of the global Disposable Urinary Catheter market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Intermittent Catheters
  • Indwelling Foley Catheters
  • Others

Segment by Material Type

  • Silicone Catheters
  • Latex Catheters
  • PVC Catheters
  • TPU Catheters

Segment by User Group

  • Pediatric Catheters
  • Adult Catheters

Segment by Application

  • Hospitals and Clinics
  • Homecare
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Disposable Urinary Catheter market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals and Clinics, Homecare, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Disposable Urinary Catheter Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$3.21B
2025
Forecast
$5B
2032
CAGR
6.4%
2025–2032
Regionen
5
global
Key companies
ColoplastHollisterTeleflexB. BraunBDConvatecWellspect HealthCareMedline Industries
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Intermittent CathetersIndwelling Foley CathetersOthers
By Application
Hospitals and ClinicsHomecareOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Intermittent Catheters
  • 3.1.3 Indwelling Foley Catheters
  • 3.1.4 Others
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals and Clinics
  • 4.1.3 Homecare
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Coloplast
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Hollister
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Teleflex
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 B. Braun
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 BD
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Convatec
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Wellspect HealthCare
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Medline Industries
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Cardinal Health
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Cook Medical
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Urocare Products
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Create Medic
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Fuji Systems
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Well Lead Medical
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Baihe Medical
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 KDL Medical
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Weigao Group
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Disposable Urinary Catheter market size?
The global Disposable Urinary Catheter market is estimated at US$ 3.21 billion in 2025 (base year) and is projected to reach US$ 4.77 billion by 2032.
What growth rate is expected for the Disposable Urinary Catheter market through 2032?
The market is expected to grow at a CAGR of 6.4% from 2026 to 2032, expanding from US$ 3.21 billion in 2025 to US$ 4.77 billion in 2032, roughly 1.5 times its base-year value.
How is Disposable Urinary Catheter defined?
Disposable urinary catheters are sterile single-use or short-term catheter products designed for urine drainage, bladder management, intraoperative urine-output monitoring and urological procedures. They are commonly made from medical-grade latex, PVC, silicone, TPU or other biocompatible materials, and can be classified into disposable intermittent catheters, disposable indwelling Foley catheters, hydrophilic-coated catheters and antimicrobial or anti-infection catheters.
What are the main segments of the Disposable Urinary Catheter market by type?
By type, the market is segmented into Intermittent Catheters, Indwelling Foley Catheters and Others.
Which applications drive demand in the Disposable Urinary Catheter market?
Key applications covered include Hospitals and Clinics, Homecare and Others.
Who are the key players in the Disposable Urinary Catheter market?
Key players profiled include Coloplast, Hollister, Teleflex, B. Braun, BD, Convatec, Wellspect HealthCare and Medline Industries, among 17 companies covered in total.
Which regions and countries are covered for Disposable Urinary Catheter?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Disposable Urinary Catheter market?
The disposable urinary catheter market is mainly driven by population aging, rising surgical volumes, increasing prevalence of urological diseases and neurogenic bladder, and growing demand for long-term care and home-based care.
Who should buy the Disposable Urinary Catheter market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals and Clinics, Homecare and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Disposable Urinary Catheter market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.